Korean J Dermatol.  1997 Aug;35(4):720-728.

Clinical and Histopathological Characteristics of Trichrome Vitiligo

Affiliations
  • 1Department of Dermatology, Yonsei University College of Medicine, Seoul, Korea.

Abstract

BACKGROUND: The term trichrome vitiligo was first suggested in 1964 by Fitzpatrick, There is a tan zone of varying width between the normal and the totally depigmented skin and this exhibits the intermediate hue. The etiopathogenesis and the histopathological characteristics of trichrome vitiligo are unknown.
OBJECTIVE
Our purpose was to evaluate the clinical and histopathological characteristics of trichrome vitiligo. Methods . Four punch biopsies were taken from twenty-one patients with trichrome vitiligo; from vitiliginous skin, light brown skin, perilesional normal skin and normal skin as far as 5cm from the nearest vitiligo spot. The sections were stained with hematoxylin-eosin and S-100 protein.
RESULTS
1. Trichrome vitiligo occurred mostly on the trunk in active vitiligo vulgaris. 2. Vacuolar degeneration of the basal cell layer in the epidermis and mild inflammatory cell infiltration in the epidermis and dermis were more prominent in light, brown skin and perilesional normal skin than in vitiliginous skin and normal skin of trichrome vitiligo. 3. The number of melanocytes was decreased in light brown skin compared with perilesional normal skin(p<0.05), and in vitiligonous skin compared with light brown skin(p<0.05), 4. A few melanocytes were also observed in vitiliginous skin of trichrome vitiligo. 5. In the trichrome vitiligo, the result of treatment was excellent in cases of systemic PUVA therapy.
CONCLUSION
Melanocytes, keratinocytes and lymphocytes may be involved in the genesis of depigmentation in trichrome vitiligo, which means cell-mediated immunity may play an important role in the pathogenesis of trichrome vitiligo.

Keyword

Trichrome vitiligo; Histopathology; Melanocyte

MeSH Terms

Biopsy
Dermis
Epidermis
Humans
Immunity, Cellular
Keratinocytes
Lymphocytes
Melanocytes
PUVA Therapy
S100 Proteins
Skin
Triacetoneamine-N-Oxyl
Vitiligo*
S100 Proteins
Triacetoneamine-N-Oxyl
Full Text Links
  • KJD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr